Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

This specifically involved distinguishing between Alzheimer's disease, the most common form of dementia, and Lewy body ...

All 16 of Indiana’s designated senior care organizations — known as Area Agencies on Aging — are now required to have a ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

Effectively treating and preventing this common form of dementia will require a cocktail of drugs and a combination of ...

The way in which we walk might hold the key to diagnosing Alzheimer's, or other types of dementia. Ground-breaking research ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

China aims to have a sweeping action plan for dementia in place by 2030, encompassing all aspects of the disease, from ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...